FILE PHOTO: A nursing home worker receives the AstraZeneca COVID-19 vaccine at a health care centre as South Korea starts a vaccination campaign against the coronavirus disease (COVID-19), in Seoul, South Korea February 26, 2021. REUTERS/Heo Ran/File Photo
SEOUL (Reuters) - South Korean authorities said on Wednesday they are investigating the deaths of two people, both with pre-existing conditions, who died within days of receiving AstraZeneca's COVID-19 vaccine.
A 63-year-old nursing home patient with cerebrovascular disease, developed symptoms including high fever, after being given the vaccine four days ago, Korea Disease Control and Prevention Agency (KDCA) Director Jeong Eun-kyeong told a briefing.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
